netFormulary Leicestershire Health Community NHS
Medicines Formulary  
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.03.02  Expand sub section  Glucocorticoid therapy
Hydrocortisone sodium succinate injection
View adult BNF View SPC online
First Choice
Green
For disease suppression 
Prednisolone
View adult BNF View SPC online
First Choice
Green
For disease suppression.
Enteric coated tablets are not routinely stocked at UHL.
The potential advantage of soluble or enteric coated preparations to reduce the risk of gastric ulcers is speculative. They are considerably more costly.
Prednisolone soluble can be up to 200 times more costly than plain tablets depending on the setting. Plain tablets can be crushed and dispersed (unlicensed).

 
Dexamethasone
View adult BNF View SPC online
Second Choice
Green
For disease suppression. Preferred choice in cerebral oedema as it has less mineralocorticoid activity. Also used in vomiting associated with cancer chemotherapy.
 
   
Methylprednisolone sodium succinate injection
View adult BNF View SPC online
Second Choice
Amber Simple
For disease suppression when larger doses of corticosteroid are required. 
   
 ....
 Non Formulary Items
Prednisolone EC

View adult BNF View SPC online Track Changes
Non Formulary
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety. All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry   

Red

Drugs which should be prescribed only by hospital specialists (clinical review by specialist as appropriate and annually as a minimum).  

Amber SCA

Drugs which would initially be prescribed by a hospital specialist and then by a GP where full agreement to share the care of each specific patient has been reached under a LMSG Shared Care Agreement (SCA). Specific patient monitoring or intervention required.   

Amber Simple

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.  

Green Conditional

Drugs for which GPs are able to take full responsibility for prescribing and monitoring subject to specified conditions e.g. prescribing in line with agreed LMSG guidance or able to demonstrate suitable competence see comments under individual entries.   

Green

Drugs for which GPs would normally take full responsibility for prescribing and monitoring. Drugs included in this list have been specifically considered by LMSG.   

netFormulary